Some of the chemotherapy drugs widely used for adjuvant and neoadjuvant chemo are Adriamycin, Ellence, Taxol, Taxotere, Cytoxan, Paraplatin, Abraxane, Navelbine, Xeloda, Gemzar, Ixempra, Halaven. All these chemotherapy drugs work on different phases of cell cycle. In chemotherapy, drugs can be given as monotherapy or in combination therapy. Chemotherapy drugs have a lot of side effects.
During chemotherapy drugs treatment, many healthy normal cells get affected. According to the American Cancer Society Cancer statistics report 2018, newly diagnosed cancer cases is estimated to be 1,735,350 and around 609,640 cancer deaths occur in the United States.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/27301
Moreover, according to Cancer Research U.K., 17 million new cancer cases were estimated worldwide and 9.6 million cancer deaths were recorded in 2018 and are projected to increase at an incidence rate of 62% worldwide during the forecast period 2018-2040.
Chemotherapy has both pros and cons. The global chemotherapy drugs have significant potential that will drive the market. After an early stage cancer surgery, most of the oncologist follow chemotherapy drugs treatment to prevent further multiplication of cancerous cells which as a result will boost the chemotherapy drugs market.
Apart from this, chemotherapy drugs have multiple benefits such as it helps to shrink the tumor cells, it reduces the growth of cancerous cells thereby increasing the life span of a person which as a result will increase the growth of chemotherapy drugs market.
Development of treatment-related side effects is one of the significant disadvantages which may restrain the growth of chemotherapy drugs. Chemotherapy treatment is a time-consuming and lengthy process.
Henceforth the chemotherapy drugs market may face challenges in the coming years as a new alternative has been developed such as immunotherapy, gene therapy and also high treatment cost may adversely affect the chemotherapy drugs market.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/27301
Immunotherapy has become the area of interest in the treatment of cancer as it enhances the immune system to fight against the cancerous cells and also patients have minimal side effects unlike conventional therapies like chemotherapy or radiation. All these alternatives may suppress the growth of overall chemotherapy drugs market.
Market Segmentation:
types |
|
route of administration |
|
distributional channel. |
|
The Asia Pacific also have the potential to increase the global chemotherapy drugs market due to the rising prevalence of cancer in this region and increasing government initiatives for public health policies is likely to drive the global chemotherapy drugs market.
The Middle East and Africa are shown to have less potential in chemotherapy drugs market due to low budget in healthcare spending, inappropriate treatment facilities which overall may impact the overall chemotherapy drugs treatment.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/27301
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com